Literatur
-
1
Arnesen E, Huseby N E, Brenn T et al.
The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population.
Scand J Clin Lab Invest.
1986;
46
63-70
-
2
La V ecchia.
Coffee, liver enzymes, cirrhosis and liver cancer.
J Hepatol.
2005;
42
444-446
-
3
Freedman N D, Curto T M, Lindsay K L et al.
Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C.
Gastroenterology.
2011;
140
1961-1969
-
4
Fix O K.
Does a latte a day keep the hepatologist away?.
Hepatology.
2008;
47
348-351
-
5
Ruhl C E, Everhart J E.
Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States.
Gastroenterology.
2005;
129
1928-1936
-
6
Honjo S, Kono S, Coleman M P et al.
Coffee drinking and serum gamma-glutamyltransferase: an extended study of Self-Defense Officials of Japan.
Ann Epidemiol.
1999;
9
325-331
-
7
Birerdinc A, Stepanova M, Pawloski L et al.
Caffeine is protective in patients with non-alcoholic fatty liver disease.
Aliment Pharmacol Ther.
;
[epub ahead of print]
-
8
Molloy J W, Calcagno C J, Williams C D et al.
Association of coffee and caffeine consumption with fatty liver disease, non-alcoholic steatohepatitis, and degree of hepatic fibrosis.
Hepatology.
;
[epub ahead of print]
-
9
Vitaglione P, Morisco F, Mazzone G et al.
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.
Hepatology.
2010;
52
1652-1661
-
10
Ong A, Wong V W, Wong G L et al.
The effect of caffeine and alcohol consumption on liver fibrosis – a study of 1045 Asian hepatitis B patients using transient elastography.
Liver Int.
2011;
31
1047-1053
-
11
Freedman N D, Everhart J E, Lindsay K L et al.
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Hepatology.
2009;
50
1360-1369
-
12
Costentin C E, Roudot-Thoraval F, Zafrani E S et al.
Association of caffeine intake and histological features of chronic hepatitis C.
J Hepatol.
2011;
54
1123-1129
-
13
Lopez-Garcia E, van Dam R M, Qi L et al.
Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women.
Am J Clin Nutr.
2006;
84
888-893
-
14
van Dam R M, Hu F B.
Coffee consumption and risk of type 2 diabetes: a systematic review.
JAMA.
2005;
294
97-104
-
15
Moreno M G, Chavez E, Aldaba-Muruato L R et al.
Coffee prevents CCl(4)-induced liver cirrhosis in the rat.
Hepatol Int.
2011;
5
857-863
-
16
Patrizia C arrieri, Cohen J, Salmon-Ceron D et al.
Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: Results from ANRS CO13 HEPAVIH.
J Hepatol.
;
[epub ahead of print]
-
17
Klatsky A L, Armstrong M A, Friedman G D.
Coffee, tea, and mortality.
Ann Epidemiol.
1993;
3
375-381
-
18
Bravi F, Bosetti C, Tavani A et al.
Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.
Hepatology.
2007;
46
430-435
-
19
La Vecchia C, Tavani A.
Coffee and cancer risk: an update.
Eur J Cancer Prev.
2007;
16
385-389
-
20
Gressner O A.
Less Smad2 is good for you! A scientific update on coffee’s liver benefits.
Hepatology.
2009;
50
970-978
-
21
Montella M, Polesel J, La Vecchia C et al.
Coffee and tea consumption and risk of hepatocellular carcinoma in Italy.
Int J Cancer.
2007;
120
1555-1559
-
22
Wedick N M, Brennan A M, Sun Q et al.
Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial.
Nutr J.
2011;
10
93
-
23
Cavin C, Holzhaeuser D, Scharf G et al.
Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity.
Food Chem Toxicol.
2002;
40
1155-1163
-
24
Shen T, Park Y C, Kim S H et al.
Nuclear factor-kappaB/signal transducers and activators of transcription-1-mediated inflammatory responses in lipopolysaccharide-activated macrophages are a major inhibitory target of kahweol, a coffee diterpene.
Biol Pharm Bull.
2010;
33
1159-1164
-
25
Kawachi I, Colditz G A, Stone C B.
Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis.
Br Heart J.
1994;
72
269-275
-
26
Riksen N P, Rongen G A, Smits P.
Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease.
Pharmacol Ther.
2009;
121
185-191
PD Dr. med. Matthias Dollinger
Klinik für Innere Medizin I
Martin-Luther-Universität Halle-Wittenberg
Ernst-Grube-Straße 40
06120 Halle (Saale)
Email: matthias.dollinger@medizin.uni-halle.de
